Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Platelet function profiles in patients with diabetes mellitus.

Rollini F, Franchi F, Muñiz-Lozano A, Angiolillo DJ.

J Cardiovasc Transl Res. 2013 Jun;6(3):329-45. doi: 10.1007/s12265-013-9449-0. Epub 2013 Feb 13. Review.

PMID:
23404189
2.
3.

Dual antiplatelet therapy in patients with diabetes mellitus: special considerations.

Capranzano P, Capodanno D.

Expert Rev Cardiovasc Ther. 2013 Mar;11(3):307-17. doi: 10.1586/erc.13.3. Review.

PMID:
23469911
4.
5.

The platelet in diabetes: focus on prevention of ischemic events.

Colwell JA, Nesto RW.

Diabetes Care. 2003 Jul;26(7):2181-8. Review.

PMID:
12832332
6.

Antiplatelet therapy in patients with diabetes mellitus.

Grove EL, Gregersen S.

Curr Vasc Pharmacol. 2012 Jul;10(4):494-505. Review.

PMID:
22272895
7.

Antiplatelet effect of aspirin in patients with coronary artery disease.

Grove EL.

Dan Med J. 2012 Sep;59(9):B4506. Review.

PMID:
22951204
8.

Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists.

Angiolillo DJ, Suryadevara S, Capranzano P, Zenni MZ, Guzman LA, Bass TA.

Catheter Cardiovasc Interv. 2009 Jan 1;73(1):1-14. doi: 10.1002/ccd.21782. Review.

PMID:
19089929
9.

Platelet dysfunction in central obesity.

Anfossi G, Russo I, Trovati M.

Nutr Metab Cardiovasc Dis. 2009 Jul;19(6):440-9. doi: 10.1016/j.numecd.2009.01.006. Epub 2009 Apr 5. Review.

PMID:
19346117
10.

Platelet function testing and tailored antiplatelet therapy.

Janssen PW, ten Berg JM.

J Cardiovasc Transl Res. 2013 Jun;6(3):316-28. doi: 10.1007/s12265-013-9458-z. Epub 2013 Mar 30. Review.

PMID:
23543615
11.

Resistance to aspirin and thienopyridines in diabetes mellitus and metabolic syndrome.

Anfossi G, Russo I, Trovati M.

Curr Vasc Pharmacol. 2008 Oct;6(4):313-28. Review.

PMID:
18855719
12.

Baseline platelet activity and response after clopidogrel in 257 diabetics among 822 patients with coronary artery disease.

Serebruany V, Pokov I, Kuliczkowski W, Chesebro J, Badimon J.

Thromb Haemost. 2008 Jul;100(1):76-82. doi: 10.1160/TH08-03-0136.

PMID:
18612541
13.

Blood platelet abnormalities and pharmacological modulation of platelet reactivity in patients with diabetes mellitus.

Watala C, Boncler M, Gresner P.

Pharmacol Rep. 2005;57 Suppl:42-58. Review.

PMID:
16415486
14.

Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy.

Angiolillo DJ, Bernardo E, Capodanno D, Vivas D, Sabaté M, Ferreiro JL, Ueno M, Jimenez-Quevedo P, Alfonso F, Bass TA, Macaya C, Fernandez-Ortiz A.

J Am Coll Cardiol. 2010 Mar 16;55(11):1139-46. doi: 10.1016/j.jacc.2009.10.043.

15.

Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapy.

Angiolillo DJ, Capranzano P, Ferreiro JL, Ueno M, Capodanno D, Dharmashankar K, Darlington A, Sumner S, Desai B, Charlton RK, Box LC, Zenni M, Guzman LA, Bass TA.

Thromb Haemost. 2011 Aug;106(2):253-62. doi: 10.1160/TH11-01-0041. Epub 2011 May 26.

PMID:
21614414
16.

Thresholds for platelet reactivity to predict clinical events after coronary intervention are different in patients with and without diabetes mellitus.

Mangiacapra F, Peace A, Barbato E, Patti G, Gatto L, Ricottini E, De Bruyne B, Di Sciascio G, Wijns W.

Platelets. 2014;25(5):348-56. doi: 10.3109/09537104.2013.824562. Epub 2013 Aug 23.

PMID:
23971913
17.

Platelet abnormalities in diabetes mellitus.

Ferreiro JL, Gómez-Hospital JA, Angiolillo DJ.

Diab Vasc Dis Res. 2010 Oct;7(4):251-9. doi: 10.1177/1479164110383994. Epub 2010 Oct 4. Review.

PMID:
20921090
18.

Optimizing antiplatelet therapy following percutaneous coronary intervention: clinical pathways for platelet function testing.

Lassar TA, Simon DI, Croce K.

Rev Cardiovasc Med. 2011;12 Suppl 1:S23-33. Review.

PMID:
22080984
19.

Platelets and antiplatelet therapy in patients with diabetes mellitus.

Arjomand H, Roukoz B, Surabhi SK, Cohen M.

J Invasive Cardiol. 2003 May;15(5):264-9. Review.

PMID:
12730635
20.

The role of calpain in diabetes-associated platelet hyperactivation.

Randriamboavonjy V, Fleming I.

Adv Pharmacol. 2010;59:235-57. doi: 10.1016/S1054-3589(10)59008-2. Review.

PMID:
20933204

Supplemental Content

Support Center